PRITEBEGENE ZEPADENOVEC
UNII 2FFJ8WJ6EM

Substance Identification & Data

This profile provides standardized clinical and technical data for Pritebegene Zepadenovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2FFJ8WJ6EM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2857059-64-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2FFJ8WJ6EM

CAS Registry Number

2857059-64-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PRITEBEGENE ZEPADENOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211719

National Cancer Institute reference terminology for clinical and research data.

INN ID

12931

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pritebegene Zepadenovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PRITEBEGENE ZEPADENOVEC

Common Names & Synonyms

DNA (REPLICATION-DEFICIENT SIMIAN ADENOVIRAL OX1 .DELTA.E1 .DELTA.E3 E4-MODIFIED CHADOX1-HBV VECTOR HUMAN CYTOMEGALOVIRUS PROMOTER PLUS HEPATITIS B VIRUS PRE-C PROTEIN FUSED WITH CORE ANTIGEN FUSED WITH NON-FUNCTIONAL POLYMERASE FUSED WITH C-TERMINAL FRAGMENT OF PRE-S1 PROTEIN FUSED WITH PRE-S2 PROTEIN FUSED WITH F2A SELF-CLEAVING PEPTIDE FUSED WITH N-TERMINAL FRAGMENT OF PRE-S1 PROTEIN FUSED WITH HEPATITIS B VIRUS SURFACE ANTIGEN CODON-OPTIMIZED TRANSGENE PLUS BOVINE GROWTH HORMONE POLYADENYLATION SIGNAL)

PRITEBEGENE ZEPADENOVEC [INN]

REPLICATION-DEFICIENT CHIMPANZEE ADENOVIRUS VECTOR (CHADOX1-.DELTA.E1 .DELTA.E3 E4-MODIFIED), ENCODING A CODON-OPTIMIZED FUSION PROTEIN CONTAINING MULTIPLE HEPATITIS B VIRUS (HBV) ANTIGENS, COMPRISING THE HBV PRE-CORE ANTIGEN, CORE ANTIGEN, A NONFUNCTIONAL POLYMERASE, A C-TERMINAL FRAGMENT OF THE HBV PRE-S1 PROTEIN AND THE PRE-S2 PROTEIN, ALL PRECEDED BY A SHARK INVARIANT (SLI) CHAIN SEQUENCE AND SEPARATED BY A SELF-CLEAVING FOOT-ANDMOUTH VIRUS F2A PEPTIDE SEQUENCE FROM THE LEADER SEQUENCE OF HUMAN TISSUE PLASMINOGEN ACTIVATOR, FOLLOWED BY AN N-TERMINAL FRAGMENT OF THE HBV PRE-S1 PROTEIN AND THE HBV SURFACE ANTIGEN (HBSAG), UNDER CONTROL OF A HUMAN CYTOMEGALOVIRUS (CMV) PROMOTER AND A BOVINE GROWTH HORMONE POLYADENYLATION SIGNAL. THE TRANSGENE IS INSERTED IN THE DELETED E1 REGION OF THE VIRAL VECTOR GENOME GENE THERAPY (IMMUNE

External Clinical & Regulatory Resources

Previous UNII2FFG8F7U66

Next UNII2FFK36Z92Z